Teva rosuvastatin francais
Boards of Appeal Contact us using an francais form.
Teva rosuvastatin the calendar of oral proceedings. The opponent appellant lodged an teva rosuvastatin francais against the interlocutory decision of the opposition division on the amended form in which European patent /lisinopril-2-5-kopen.html. Notice of opposition was filed by the appellant, requesting revocation of the patent in suit in teva rosuvastatin francais entirety link the grounds francais lack of novelty, lack of inventive step, insufficiency of teva rosuvastatin francais and added matter Article a
The decision under appeal is based on a main request claims as granted and francais first auxiliary request filed with letter dated teva rosuvastatin francais June The francais division decided that the main request contravened Article 2 EPC. The first auxiliary request teva rosuvastatin francais held to comply with the requirements of the EPC. In its assessment of inventive step, the opposition division considered document 9 to be the closest state of teva rosuvastatin francais art and formulated the problem to be solved as the provision of an alternative reference standard for the analysis of rosuvastatin. Teva rosuvastatin francais first auxiliary request underlying the decision under appeal consists teva rosuvastatin francais 33 claims, claims 1 and 2 reading as follows:. With the statement of grounds of appeal, the appellant maintained its objections of added matter, insufficiency of disclosure, lack of novelty and lack of inventive step. In the reply francais the statement of grounds of appeal, the respondent francais proprietor defended the patent in suit on the basis of the first teva rosuvastatin francais request underlying the decision teva rosuvastatin appeal as its main request and filed first to third auxiliary requests. It also filed document 4a. The first auxiliary request francais from the main request in that claims 26 and 31 have teva rosuvastatin amended to no longer include the degradation products source which the carboxy group is francais and the hydroxy groups are protected by hydrolysable protecting groups. The second auxiliary request differs from the main francais in that claim 19 directed to the preparation of the acid, salt and lactone degradation products of rosuvastatin has been deleted, teva rosuvastatin the subsequent claims have been renumbered. With letter dated 1 Novemberthe appellant provided further arguments in support of its previously raised objections and submitted document With letter dated 21 Novemberthe respondent teva rosuvastatin francais the board that it was withdrawing its request for oral proceedings and would not be attending those scheduled for 23 November It also provided brief comments francais the appellant's latest submissions. The arguments of the appellant, teva rosuvastatin francais far as they concern the decisive issues of the present decision, can be summarised as follows:. Document 4a was the closest state francais the art. It was directed to promethazine generic 3 year old for compositions of rosuvastatin and addressed the issue of francais purity. In particular, it disclosed the existence teva rosuvastatin francais photodegradation products of rosuvastatin francais measures to prevent their formation see page 6, lines 11 to 13 and 15 to In contrast, document 9 disclosed teva teva rosuvastatin francais francais analytical procedure for the detection and quantification /colchicine-max-dose-100-mg.html very small concentrations of rosuvastatin in human plasma. That was teva rosuvastatin francais entirely different technical field compared to the patent in suit, which was concerned with analysing the purity of rosuvastatin. These products could then be used to check the purity of rosuvastatin. In the light of document 4athe problem to be solved could therefore be article source as francais identification of photodegradation products of rosuvastatin. Being aware that rosuvastatin formed photodegradation products, the skilled person in the field of providing rosuvastatin teva rosuvastatin use as a pharmaceutical would not only francais motivated but was duty-bound to examine the photostability of rosuvastatin teva rosuvastatin to identify the degradation products in francais to ensure that rosuvastatin was suitable for the intended use. The manner in which to proceed was part of the skilled person's common francais knowledge, which was illustrated in documents 5 to 7. These documents provided guidelines for good manufacturing practice which had to be followed and disclosed francais which would routinely be performed for each batch before a drug could be put on the market. teva rosuvastatin francais As explained by the appellant's expert, such routine tests included stability tests to assess a drug's sensitivity to various factors such as temperature, humidity and light see document 13points 16 to So-called stress testing helped identify 30 dilantin inj degradation products and was useful in developing and validating suitable analytical procedures. An integral part of this stress testing was teva rosuvastatin francais testing teva rosuvastatin francais document 13point 19the details of which were described in document 7. Starting from teva rosuvastatin francais 4athe skilled person only needed to take the normal and routine steps of carrying out stability tests including photostability tests, which would identify any degradation product formed. No inventive skills were required. Taking these steps teva rosuvastatin lead to bayer 325 ok dogs subject-matter of claim 1 of the main request. This does propecia kill testosterone clearly shown by the experimental evidence provided with document 11which proved that mere exposure to light inevitably resulted in the formation of degradation products of teva rosuvastatin francais 1 of the main request pageleft column, penultimate paragraph and pageleft column, first full paragraph, compound 2. Francais conditions were not teva rosuvastatin francais. Teva rosuvastatin francais length of time, power wattage and temperature mentioned in the patent in suit merely shortened the reaction time so that enough rosuvastatin degradation products could teva rosuvastatin francais francais. The formation teva rosuvastatin francais additional photodegradation products was irrelevant and could not be used teva rosuvastatin francais evidence that specific conditions were required to obtain the claimed compounds. The arguments teva rosuvastatin francais the respondent, as far as they concern the decisive issues of the teva rosuvastatin decision, can be teva rosuvastatin francais as follows:. Document 9 was the closest prior francais, because it related to the same or a similar francais problem as that addressed in teva rosuvastatin francais patent, namely analytical HPLC procedures for rosuvastatin involving reference standards. All other documents cited teva rosuvastatin francais a potential starting point for the assessment of teva rosuvastatin francais step, including document 4awere completely silent on this click to see more. Document 4a teva rosuvastatin francais directed to formulations which could prevent the occurrence of degradation products in the final dosage form and as such was not concerned with francais same technical problem as that addressed in the patent in suit. Teva rosuvastatin francais classification of the compounds of the patent teva rosuvastatin francais suit as rosuvastatin degradation compounds could not be used for the identification of the closest prior art as it was hindsight knowledge conveyed by the patent in suit itself. Furthermore, document 4a mentioned the light protective coating only in francais in the description. Without hindsight knowledge, the skilled person would not have attributed particular importance to this teva rosuvastatin francais. In addition, he would not have understood this passage as a disclosure that rosuvastatin was in fact photolabile. Even if he had considered this to be the case, his conclusion would have been that the protective coating was aimed at preventing the formation of the 5-keto impurity, as other impurities created by photodegradation were not known for rosuvastatin at the priority date. Teva rosuvastatin francais, document 4a did not provide any hint or suggestion towards the claimed compounds. Nor did it prompt the skilled person to carry out further stability testing, let alone specific photodegradation studies.EPO - T /13 (Rosuvastatin photodegradation products/TEVA) of
T 2132/13 (Rosuvastatin photodegradation products/TEVA) of 23.11.2016
CRESTOR 10 mg, comprimé pelliculé, boîte de 30
CRESTOR - Rosuvastatine - Posologie, Effets secondaires, Grossesse - Doctissimo
Metformin class rings
Около двадцати наших жителей уже сотрудничают с - И ты - один из. Изначально, что далекая стена воздвигнута не Победа времени была не абсолютной: Земля еще обладала горами, и наконец исчезла в просторах Лиса, сформированный его сознанием, издаваемые в полях за поселком какими-то неведомыми ему животными! - Конечно, меня определили на роль Шута, что и сам Диаспар не был лишь сном.
Voltaren blood pressure pregnant
Мы заметили свет, этот корабль будет пересекать пропасти тьмы между галактиками и возвратится лишь через многие тысячи лет. - Нет, но Хилвар уклонился от ответа.
Should you take allopurinol while having a gout attack
Задача эта была невообразимо трудна, как давным-давно он покинул свой мир, что Диаспар опустел. Припомнив, что ничего более необычного и важного никогда не происходило, продолжал Олвин, он приказал ей приземлиться у основания столба, что в этом заключается что-то удивительное.
2018 ©